Feasibility and safety of a standardized low-dose thrombolytic therapy for right-sided mechanical prosthetic valve thrombosis in adult congenital heart disease
Feasibility and safety of a standardized low-dose thrombolytic therapy for right-sided mechanical prosthetic valve thrombosis in adult congenital heart disease. // International Journal of Cardiology Congenital Heart Disease. – URL: https://www.sciencedirect.com/science/article/pii/S266666852600056X?dgcid=rss_sd_all
Feasibility and safety of a standardized low-dose thrombolytic therapy for right-sided mechanical prosthetic valve thrombosis in adult congenital heart disease. International Journal of Cardiology Congenital Heart Disease. https://www.sciencedirect.com/science/article/pii/S266666852600056X?dgcid=rss_sd_all
“Feasibility and safety of a standardized low-dose thrombolytic therapy for right-sided mechanical prosthetic valve thrombosis in adult congenital heart disease.” International Journal of Cardiology Congenital Heart Disease.
@article{article49430,
title = {Feasibility and safety of a standardized low-dose thrombolytic therapy for right-sided mechanical prosthetic valve thrombosis in adult congenital heart disease},
journal = {International Journal of Cardiology Congenital Heart Disease},
url = {https://www.sciencedirect.com/science/article/pii/S266666852600056X?dgcid=rss_sd_all}
}